Source comparison
CJC-1295 Without DAC vs With DAC: Pulsatile vs Sustained GH Elevation
The distinction between CJC-1295 without DAC and CJC-1295 with DAC determines whether the peptide produces physiological pulsatile GH release or sustained supraphysiological elevation. Both peptides share the same core GHRH analog structure, but the DAC modifi
This comparison does not assign a generated winner or score.
- The distinction between CJC-1295 without DAC and CJC-1295 with DAC determines whether the peptide produces physiological pulsatile GH release or sustained supraphysiological elevation. Both peptides share the same core GHRH analog structure, but the DAC modification. A maleimide-protected cysteine residue. Allows the peptide to form covalent bonds with serum albumin, dramatically extending its elimination half-life from 30 minutes to approximately 6–8 days.
- Half-Life
- ~30 minutes
- 6–8 days
- Without DAC requires multiple daily doses; with DAC allows weekly dosing
- GH Release Pattern
- Pulsatile (peaks 30–60 min, returns to baseline in 2–3 hours)
- Sustained elevation (continuous supraphysiological GH for 7+ days)
- Without DAC mirrors natural circadian rhythm; with DAC overrides feedback inhibition
- Dosing Frequency
- 2–3x daily (typically paired with GHRP at each administration)
- 1x weekly (or twice weekly in some protocols)
- Without DAC demands strict timing; with DAC offers convenience at the cost of physiological deviation
- Somatostatin Sensitivity
- Fully responsive. GH release suppressed when somatostatin tone is high
- Partially bypasses somatostatin inhibition due to prolonged receptor occupancy
- Without DAC respects natural feedback; with DAC can produce GH elevation even during periods when endogenous secretion should be low
- Receptor Desensitization Risk
- Minimal. Short receptor occupancy allows recovery between pulses
- Moderate. Prolonged agonism may downregulate GHRH receptor expression
- Without DAC preserves receptor sensitivity; with DAC may require washout periods
- Research Application Context
- Studies examining pulsatile GH dynamics, circadian secretion patterns, or acute GH effects
- Studies requiring sustained GH elevation without frequent dosing (chronic exposure models)
- Use without DAC for physiological modeling; with DAC for convenience in long-duration protocols
- Growth hormone's biological effects are critically dependent on pulsatile secretion. Continuous GH exposure suppresses downstream IGF-1 production due to negative feedback on hepatic GH receptors, and sustained elevation increases insulin resistance through interference with insulin receptor substrate-1 (IRS-1) signaling. Research published in Endocrinology demonstrated that pulsatile GH administration produced 2.3× greater IGF-1 elevation compared to continuous infusion delivering the same total GH dose over 24 hours. The temporal pattern of receptor engagement matters more than total exposure.
- For researchers investigating physiological GH dynamics, metabolic effects, or receptor signaling pathways, CJC-1295 without DAC offers a model that more closely approximates natural hypothalamic-pituitary function. For convenience in chronic administration protocols where strict physiological mimicry isn't the primary endpoint, CJC-1295 with DAC reduces handling complexity. Real Peptides supplies both formulations with identical quality standards. The choice depends entirely on the research question being addressed. You can explore both options through our CJC-1295 NO DAC product or review combination protocols like our CJC1295 Ipamorelin stack.